CEBP 09 AM Call for Abstracts w/deadline 09 AM Call for Abstracts w/deadline
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kolonel, L. N.
Right arrow Articles by Stemmermann, G. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kolonel, L. N.
Right arrow Articles by Stemmermann, G. N.

Cancer Epidemiology Biomarkers & Prevention, Vol 3, Issue 3 225-228, Copyright © 1994 by American Association for Cancer Research


ARTICLES

Relationship of serum uric acid to cancer occurrence in a prospective male cohort

LN Kolonel, C Yoshizawa, AM Nomura and GN Stemmermann
Cancer Research Center, University of Hawaii, Honolulu 96813.

Uric acid is a potent antioxidant and thus might protect against cancer. To test this hypothesis, we examined the relationship of serum uric acid to subsequent cancer incidence in a cohort of Japanese men in Hawaii. The study population consisted of 7889 men identified in the years 1965-1968 and followed by active hospital surveillance through November 1991. Cancer risk by serum uric acid level was analyzed using Cox proportional hazards regression with adjustment for age and, where indicated, smoking, alcohol use, and body mass index. No significant associations were seen for total cancer (1544 cases), or for cancers of the stomach (214), colon (272), rectum (105), lung (223), bladder (89), or hematopoietic system (77). For prostate cancer (293 cases), a positive association was found (relative risk for highest versus lowest quartile of serum uric acid = 1.5; 95% confidence interval 1.1-2.1; p for trend = 0.04). When the interval from examination to diagnosis was considered, this association was strongest for cases diagnosed in the first 10 years, was attenuated after 15 years, and disappeared completely after 20 years. The findings from this study do not support the hypothesis that uric acid protects against cancer occurrence.


This article has been cited by other articles:


Home page
Clin. Chem.Home page
A. Strasak, E. Ruttmann, L. Brant, C. Kelleher, J. Klenk, H. Concin, G. Diem, K. Pfeiffer, H. Ulmer, and and the VHM&PP Study Group
Serum Uric Acid and Risk of Cardiovascular Mortality: A Prospective Long-Term Study of 83 683 Austrian Men
Clin. Chem., February 1, 2008; 54(2): 273 - 284.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
A. M. Strasak, K. Rapp, W. Hilbe, W. Oberaigner, E. Ruttmann, H. Concin, G. Diem, K. P. Pfeiffer, H. Ulmer, and On behalf of the VHM&PP Study Group
The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women
Ann. Onc., November 1, 2007; 18(11): 1893 - 1897.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. M. Gapstur, P. H. Gann, W. Lowe, K. Liu, L. Colangelo, and A. Dyer
Abnormal Glucose Metabolism and Pancreatic Cancer Mortality
JAMA, May 17, 2000; 283(19): 2552 - 2558.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.